更正：HER2抑制作用会增加非肌肉肌球蛋白IIA，从而促进HER2阳性乳腺癌的肿瘤发生。
Correction: HER2 inhibition increases non-muscle myosin IIA to promote tumorigenesis in HER2+ breast cancers.
出版信息
PLoS One. 2024 Dec 10;19(12):e0315773. doi: 10.1371/journal.pone.0315773. eCollection 2024.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0285251.].
摘要
[本文更正了文章的数字对象标识符：10.1371/journal.pone.0285251。]
相似文献
1
Correction: HER2 inhibition increases non-muscle myosin IIA to promote tumorigenesis in HER2+ breast cancers.
PLoS One. 2024 Dec 10;19(12):e0315773. doi: 10.1371/journal.pone.0315773. eCollection 2024.
2
HER2 inhibition increases non-muscle myosin IIA to promote tumorigenesis in HER2+ breast cancers.
PLoS One. 2023 May 18;18(5):e0285251. doi: 10.1371/journal.pone.0285251. eCollection 2023.
3
Correction: Trastuzumab effects depend on HER2 phosphorylation in HER2-negative breast cancer cell lines.
PLoS One. 2020 Oct 15;15(10):e0241089. doi: 10.1371/journal.pone.0241089. eCollection 2020.
4
Correction: Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast Cancer.
PLoS One. 2017 Oct 11;12(10):e0186551. doi: 10.1371/journal.pone.0186551. eCollection 2017.
5
Correction: An Experimental Analysis of the Molecular Effects of Trastuzumab (Herceptin) and Fulvestrant (Falsodex), as Single Agents or in Combination, on Human HR+/HER2+ Breast Cancer Cell Lines and Mouse Tumor Xenografts.
PLoS One. 2024 Sep 23;19(9):e0311128. doi: 10.1371/journal.pone.0311128. eCollection 2024.
6
Correction: Myosin Light Chain Kinase (MLCK) Gene Influences Exercise Induced Muscle Damage during a Competitive Marathon.
PLoS One. 2016 Dec 9;11(12):e0168309. doi: 10.1371/journal.pone.0168309. eCollection 2016.
7
Correction: Cryo-EM Structure of HER2-trastuzumab-pertuzumab complex.
PLoS One. 2019 May 28;14(5):e0217716. doi: 10.1371/journal.pone.0217716. eCollection 2019.
8
Correction: New Isoform of Cardiac Myosin Light Chain Kinase and the Role of Cardiac Myosin Phosphorylation in α1-Adrenoceptor Mediated Inotropic Response.
PLoS One. 2024 Dec 4;19(12):e0315236. doi: 10.1371/journal.pone.0315236. eCollection 2024.
9
Correction: Inhibition of p38 MAPK Signaling Augments Skin Tumorigenesis via NOX2 Driven ROS Generation.
PLoS One. 2017 Feb 14;12(2):e0172451. doi: 10.1371/journal.pone.0172451. eCollection 2017.
10
Correction: Distribution and evolution of stable single α-helices (SAH domains) in myosin motor proteins.
PLoS One. 2017 May 11;12(5):e0177716. doi: 10.1371/journal.pone.0177716. eCollection 2017.
本文引用的文献
1
HER2 inhibition increases non-muscle myosin IIA to promote tumorigenesis in HER2+ breast cancers.
PLoS One. 2023 May 18;18(5):e0285251. doi: 10.1371/journal.pone.0285251. eCollection 2023.
Zotero 插件